Cardiovascular Diseases in the Era of Precision Medicine

Dear Colleagues,

This Special Issue aims to highlight the latest advancements in the detection, treatment and management of cardiovascular diseases through the application of precision medicine. We welcome submissions that delve into aspects of experimental and laboratory medicine, focusing on the innovative methodologies and technologies driving personalized cardiovascular care. The scope of this Specail Issue includes, but is not limited to, the folloiwng topics:

• Cutting-edge diagnostic tools and techniques tailored to individual patient profiles.
• Biosignal and other big data analysis for the detection and prediction of cardiovascular conditions.
• The application of genomics, proteomics and metabolomics in developing personalized cardiovascular treatments.
• Advances in imaging technologies for accurate and detailed cardiovascular assessments.
• Personalized therapeutic strategies and their impact on patient outcomes.
• The integration of multi-omics data to enhance our understanding and treatment of cardiovascular diseases.
• Ethical considerations and challenges in the implementation of precision medicine within cardiology.

We encourage the submission of papers that reflect current research trends and advancements in precision medicine, offering insights into how these innovations are shaping the future of cardiovascular disease management.

Dr. Panteleimon Pantelidis
Dr. Polychronis E. Dilaveris
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.